Lung cancer or bronchogenic carcinoma is the number one cause of deaths all around the world. Lung cancer like all cancers or malignant tumors, results from an abnormality in the body’s basic unit of life. All cancers also called – carcinomas.

The body maintains a system of checks and balances on cell growth, cells health and other toxins/waste materials to help in organism keep healthy environment. Disruption of this system of “cleaning and checks δ balances results in fungus production, these Fungi causes a proliferation of cells that eventually forms a mass known as a tumor, said Dr Qaisar Ahmed MD, DHMS.

Tumors can be benign or malignant. Tumors do not spread to other parts of the body. Malignant tumors, on the other hand, often grow aggressively locally where they start, they also can enter the bloodstream or lymphatic system and then spread to other organs of the body (adrenal glands, liver, brain, bones etc).

Cancers from anywhere in the body may spread to the lungs either through the bloodstream, through the lymphatic system, or directly from nearby organs. Metastatic tumors are most often multiple, scattered throughout the lung, and concentrated in the peripheral rather than central areas of the lung causing lung cancer.

This process of spread is called metastasis; the areas of tumor growth at these distant sites are called metastases. Lung cancer tends to spread or metastasize very early after it forms, that’s why it is a very life-threatening cancer and is most difficult to treat.

Metastases

The lung also is a very common site for metastasis from malignant tumors in other parts of the body. The same types of cells as the original (primary) tumor make up tumor metastases. For example, if prostate cancer spreads to the lungs, it is metastatic prostate cancer in the lung.

Bronchogenic carcinoma can arise in any part of the lung, but more than 90% of cancers of the lung arise from the epithelial cells, the cells lining the larger and smaller airways (bronchi and bronchioles); for this reason, lung cancers are sometimes called bronchogenic cancers of bronchogenic carcinomas.

Cancers also can arise from the pleura (called mesotheliomas) or rarely from supporting tissues within the lungs, for example, the blood vessels.

Causes and risk factors for Bronchogenic Carcinoma

Common causes of lung cancer include:

• Active and/or passive Smoking
• Exposure to asbestos fibers,
• Exposure to gases especially radon,
• Exposure to the radiation (directly or indirectly),
• Familial predisposition,
• Chronic lung diseases,
• Air pollutions especially chemical factories,
• Exposure to naphtha exhaust.

Types of Bronchogenic carcinoma

Lung cancers (bronchogenic carcinomas) are divided into two main types: small-cell lung cancers (SCLC) and non-small-cell lung cancers (NSCLC). This classification depends upon the microscopic appearance of the tumor cells themselves, specifically the size of the cells.

Small-cell lung cancers (SCLC)

Comprise about 20% of lung cancers and are the most aggressive and rapidly growing of all lung cancers. SCLC metastasizes rapidly to many organs and is most often discovered after they have spread extensively. Referring to a specific cell appearance often seen when examining samples of SCLC under the microscope, these cancers are sometimes called oat cell carcinomas.

Non-small-cell lung cancer (NSCLC)

Non-small-cell cancer is the most common lung cancer. NSCLC can be divided into several main types based on the type of cells found in the tumor:

• Adenocarcinomas are the most commonly seen type of NSCLC (up to 50% of NSCLC). Most adenocarcinomas arise in the outer, or peripheral, areas of the lungs.
• Squamous cell carcinomas (about 30% of NSCLC) Also known as epidermoid carcinomas; squamous cell cancers arise most frequently in the central chest area in the bronchi.
• Large cell carcinomas sometimes referred to as undifferentiated carcinomas, are the least common type of NSCLC.
• Mixtures of different types of NSCLC also are seen.

Other less common types of cancers

These types are much less common than NSCLC and SCLC (together comprise only 5%-10% of lung cancers):

Bronchial carcinoids (up to 5%). Bronchial carcinoma sometimes refers to these tumors as lung neuroendocrine tumors. They are generally small (3 cm-4 cm or less) when diagnosed and occur most commonly under 40 years of age. Carcinoid tumors can metastasize, and a small proportion of these tumors secrete hormone-like substances that may cause specific symptoms related to the hormone produced. Carcinoids generally grow and spread more slowly than bronchogenic cancers, and medical professionals detect many early enough.

Cancers of supporting lung tissue such as smooth muscle, blood vessels, or cells involved in the immune response can rarely occur in the lung.

Symptoms

Symptoms of bronchogenic carcinoma are varied depending on where and how widespread the tumor is. Warning signs of lung cancer are not always present or easy to identify. Lung cancer may not cause pain or other symptoms in some cases. A person with lung cancer may have the following kinds of symptoms:

No symptoms

In up to 25% of people, the cancer is first discovered on a routine chest X-ray or CT scan as a solitary small mass sometimes called a coin lesion, since, on a two-dimensional X-ray or CT scan, the round tumor looks like a coin. These patients with small, single masses often report no symptoms at the time of the cancer discovery.

Symptoms related to cancer

The growth of cancer and invasion of lung tissues and surrounding tissue may interfere with breathing, leading to symptoms such as cough, shortness of breath, wheezing, chest pain, and coughing up blood (hemoptysis). If cancer has invaded nerves, it may cause shoulder pain that travels down the outside of the arm (called Pancoast syndrome) or paralysis of the vocal cords leading to hoarseness. Invasion of the esophagus may lead to difficulty swallowing (dysphagia). If there is an obstruction of a large airway, collapse of a portion of the lung may occur and cause infections (abscesses, pneumonia) in the obstructed area.

Symptoms related to metastasis

Bronchogenic carcinoma that has spread to the bones may produce excruciating pain at the sites of involvement. Cancer that has spread to the brain may cause a number of neurologic symptoms like blurred vision, headaches, seizures, or symptoms of stroke such as weakness or loss of sensation in parts of the body.

Paraneoplastic symptoms

Symptoms that result from the production of hormone-like substances by the tumor cells frequently accompany lung cancers. These paraneoplastic syndromes occur most commonly with SCLC but may occur with any tumor type.

A common paraneoplastic syndrome associated with SCLC is the production of a hormone called adrenocorticotropic hormone (ACTH) by the cancer cells, leading to over secretion of the hormone cortisol by the adrenal glands (Cushing’s syndrome). The most frequent paraneoplastic syndrome seen with NSCLC is the production of a substance similar to parathyroid hormone, resulting in elevated levels of calcium in the bloodstream (hint for the Homeopathic researchers).

Nonspecific symptoms

Nonspecific symptoms are seen with many cancers, including lung cancers, weight loss, weakness, and fatigue. Psychological symptoms such as depression and mood changes also are common.

Diagnosis

There is a wide range of diagnostic procedures and tests to diagnose lung cancer for example:

The history and physical examination may reveal the presence of symptoms or signs that are suspicious for lung cancer, asking about symptoms and risk factors for cancer development such as smoking, drinking etc. Doctors may detect signs of breathing difficulties, airway obstruction, or infections in the lungs. Cyanosis, a bluish color of the skin and the mucous membranes due to insufficient oxygen in the blood suggests compromised function due to chronic disease of the lung. Likewise, changes in the tissue of the nail beds, known as clubbing, also may indicate chronic lung disease.

Radiations

• Chest X-ray.
• Computerized tomography (CT scan) may be performed to examine for both metastatic and lung tumors. Advantage of CT scans is that they are more sensitive than standard chest X-rays in the detection of lung nodules, that is, they will demonstrate more nodules. Sometimes medical professionals give intravenous contrast material before the scan to help delineate the organs and their positions.

{The side effect to intravenous contrast material given before the procedure. This may result in itching, a rash, or hives, severe anaphylactic reactions (life-threatening allergic reactions with breathing difficulties) etc}.

• The USPSTF and ACS recommend a technique called a low-dose helical CT scan (or spiral CT scan) annually in current and former smokers between ages 55 and 80.
• Magnetic resonance imaging (MRI) scans may be appropriate when precise detail about a tumor location is required.
• Positron emission tomography (PET) scanning is a specialized imaging technique that uses short-lived radioactive drugs to produce three-dimensional colored images of those drugs in the tissues within the body. PET scans measure metabolic activity and the function of tissues. PET scans can determine whether a tumor tissue is actively growing and can aid in determining the type of cells within a particular tumor.

Pet Scan

In PET scanning, the patient receives a short half-lived radioactive drug. The drug accumulates in certain tissues more than others, depending on the drug that is injected. The drug discharges particles (positrons) from whatever tissues take them up. As the positrons encounter electrons within the body, a reaction producing gamma rays occurs. A scanner records these gamma rays and maps the area where the radioactive drug has accumulated. For example, combining glucose (a common energy source in the body) with a radioactive substance will show where glucose is rapidly being used, for example, in a growing tumor.

PET scanning may also be integrated with CT scanning in a technique known as PET-CT scanning. Integrated PET-CT has been shown to improve the accuracy of staging over PET scanning alone.

Other tests required are:

Bone Scan

To determine whether lung cancer has metastasized to the bones. In a bone scan, a small amount of radioactive material is injected into the bloodstream and collects in the bones, especially in abnormal areas such as those involved by metastatic tumors. The radioactive material is detected by a scanner.

Sputum cytology

The simplest method to establish the diagnosis is the examination of sputum. If a tumor is centrally located and has invaded the airways, sputum cytology examination may allow visualization of tumor cells for diagnosis. This is the most risk-free and inexpensive tissue diagnostic procedure, but its value is limited since tumor cells will not always be present in sputum even if a cancer is present. Also, noncancerous cells may occasionally undergo changes in reaction to inflammation or injury that make them look like cancer cells.

Bronchoscopy

Examination of the airways by bronchoscopy may reveal areas of tumor that can be biopsied for diagnosis by a pathologist. A tumor in the central areas of the lung or arising from the larger airways is accessible to sampling using this technique. Bronchoscopy requires sedation or anesthesia.

Some patients may cough up dark-brown blood for one to two days after the procedure. More serious but rare complications include a greater amount of bleeding, decreased levels of oxygen in the blood, and arrhythmias as well as complications from sedative medications and anesthesia.

Needle biopsy

Fine-needle aspiration (FNA) through the skin, most commonly performed with radiological imaging for guidance, may be useful in retrieving cells for diagnosis from tumor nodules in the lungs. Needle biopsies are particularly useful when the lung tumor is peripherally located in the lung and not accessible to sampling by bronchoscopy.

This procedure is generally accurate when the tissue from the affected area is adequately sampled, but in some cases, adjacent or uninvolved areas of the lung may be mistakenly sampled. A small risk of pneumothorax accompanies the procedure.

Thoracentesis

Sometimes lung cancers involve the lining tissue of the lungs (pleura) and lead to an accumulation of fluid in the pleura (pleural effusion). Aspiration of a sample of this fluid (thoracentesis) may reveal the cancer cells and establish the diagnosis. A risk of a pneumothorax is associated with this procedure.

Major surgical procedures

If none of the aforementioned methods yields a diagnosis, employ surgical methods to obtain tumor tissue for diagnosis. These can include mediastinoscopy (examining the chest cavity between the lungs through a surgically inserted probe with biopsy of tumor masses or lymph nodes that may contain metastases) or thoracotomy (opening of the chest wall). With a thoracotomy, complete removal of lung cancer is rare, and both mediastinoscopy and thoracotomy carry the risks of major surgical procedures (complications such as bleeding, infection, and risks from anesthesia and medications).

Blood tests

While routine blood tests alone cannot diagnose lung cancer, they may reveal biochemical or metabolic abnormalities in the body that accompany cancer. For example, elevated levels of calcium or the enzyme alkaline phosphatase may accompany cancer that is metastatic to the bones. Likewise, elevated levels of certain enzymes normally present within liver cells, including aspartate aminotransferase (AST or SGOT) and alanine aminotransferase (ALT or SGPT), signal liver damage, possibly through the presence of tumor metastatic to the liver.

Molecular testing

For advanced NSCLCs, a doctor carries out molecular genetic testing to look for genetic mutations. Mutations that are responsible for tumor growth are driver mutations. For example, testing may be done to look for mutations or abnormalities in the epithelial growth factor receptor (EGFR) and the anaplastic lymphoma kinase (ALK) genes. Other genes that may mutate include MAPK and PIK3.

Determine lung cancer staging

The stage of cancer is a measure of the extent to which cancer has spread in the body. Staging involves the evaluation of cancer’s size and its penetration into surrounding tissue as well as the presence or absence of metastases in the lymph nodes or other organs.

It is also important for determining the allopathic treatment of particular cancer since lung cancer therapies are geared toward specific stages. Staging of cancer also is critical in estimating the prognosis during/after an allopathic treatment of a given patient, in allopathic treatment with higher-stage cancers generally having a worse prognosis than lower-stage cancers.

Doctors assign a stage to NSCLC from I to IV in order of severity:

• In stage I, the cancer is confined to the lung.
• In stages II and III, the cancer is confined to the chest (with larger and more invasive tumors classified as stage III).
• Stage IV cancer has spread from the chest to other parts of the body.

Most allopathic doctors use a two-tiered system to determine treatment for SCLC:

• Limited-stage (LS) SCLC refers to cancer that is confined to its area of origin in the chest.
• In extensive-stage (ES) SCLC, cancer has spread beyond the chest to other parts of the body.

Allopathic treatment for Bronchogenic carcinoma

Allopathic treatment of lung cancer requires a team approach for example:

• Surgical oncologists are surgeons specializing in the removal of cancers.
• Thoracic surgeons or general surgeons may also surgically treat lung cancers.
• Medical and radiation oncologists are specialists in the treatment of cancers with medications and radiation therapy, respectively.
• Other specialists who may be involved in the care of people with lung cancer include pain and palliative care specialists, as well as pulmonary specialists (medical pulmonologists).

Lung cancer primarily involves:

• Surgical removal of cancer,
• Chemotherapy,
• Radiation therapy,
• Combinations of these treatments.
• Targeted therapies and immunotherapy treatments are becoming more common.

The decision about which treatments will be appropriate for a given individual must take into account the location and extent of the tumor, as well as the overall health status of the patient.

As with other cancers, doctors may prescribe therapy intended to be curative (removal or eradication of cancer) or palliative (measures that are unable to cure cancer but can reduce pain and suffering). Doctors may prescribe more than one type of therapy. In such cases, the therapy that is added to enhance the effects of the primary therapy is referred to as adjuvant therapy, for example chemotherapy or radiotherapy administered after the surgical removal of a tumor in an attempt to kill any tumor cells that remain following surgery.

Stage IV Lung Cancer with ALK Rearrangement

Identification of an ALK gene rearrangement in a lung cancer is important for deciding the optimal treatment course. The ALK rearrangement means that drugs that specifically act against the abnormal fusion protein can be used. Three drugs, crizotinib, ceritinib, and alectinib, have been developed to target the activity of the abnormal fusion protein, and additional agents are under development.

For patients with advanced or metastatic ALK-positive NSCLC who do not have metastases to the brain, the ALK inhibitor crizotinib is the recommended therapy. Ceritinib or alectinib is typically given if the cancer becomes resistant to crizotinib or if the patient is unable to tolerate crizotinib.

Surgery

Doctors generally perform surgical removal of the tumor for limited-stage (stage I or sometimes stage II) NSCLC which is the treatment of choice for cancer that has not spread beyond the lung. About 10%-35% of lung cancers can be removed surgically, but removal does not always result in a cure.

Among people who have an isolated, slow-growing lung cancer removed, 25%-40% are still alive five years after diagnosis. It is important to note that although a tumor may be anatomically suitable for resection, surgery may not be possible if the person has other serious conditions (such as severe heart or lung disease) that would limit their ability to survive an operation. Surgeons perform surgery less often with SCLC than with NSCLC because these tumors are less likely to be localized to one area that can be removed.

The surgical procedure chosen depends upon the size and location of the tumor. Surgeons must open the chest wall and may perform a wedge resection of the lung (removal of a portion of one lobe), a lobectomy, or a pneumonectomy (removal of an entire lung). Sometimes lymph nodes in the region of the lungs also are removed (lymphadenectomy).

The risks of surgery include complications due to bleeding, infection, and complications of general anesthesia; side effects of drugs patient will be using later all of his/her life.

Radiation

Radiation therapy treats both NSCLC and SCLC, it may be given as curative therapy, palliative therapy (using lower doses of radiation than with curative therapy), or as adjuvant therapy in combination with surgery or chemotherapy. Medical professionals deliver the radiation either externally, by using a machine that directs radiation toward cancer, or internally through the placement of radioactive substances in sealed containers within the area of the body where the tumor is localized. Brachytherapy is a term that describes the use of a small pellet of radioactive material placed directly into cancer or into the airway next to cancer.

Therapeutic radiation can be given if a person refuses surgery, if a tumor has spread to areas such as the lymph nodes or trachea making surgical removal impossible, or if a person has other conditions that make them too ill to undergo major surgery. Radiation therapy generally only shrinks a tumor or limits its growth when given as a sole therapy.

Combined therapy

Combining radiation therapy with chemotherapy can further prolong survival when chemotherapy is administered. A patient who has severe lung disease in addition to lung cancer may not be able to receive radiotherapy to the lung since the radiation can further decrease the function of the lungs. A type of external radiation therapy called stereotactic radiosurgery is sometimes used to treat single brain metastases. In this procedure, multiple beams of radiation coming from different directions are focused on the tumor over a few minutes to hours while the head is held in place by a rigid frame. This reduces the dose of radiation that is received by non-cancerous tissues.

For external radiation therapy, a process called simulation is necessary prior to treatment. Using CT scans, computers, and precise measurements, simulation maps out the exact location where the radiation will be delivered, called the treatment field or port. The external radiation treatment itself generally is done four or five days a week for several weeks.

Micro Metastases

SCLC often spreads to the brain. Sometimes people with SCLC that are responding well to treatment are treated with radiation therapy to the head to treat very early spread to the brain (called micro metastasis) that is not yet detectable with CT or MRI scans and has not yet produced symptoms. This is known as prophylactic brain radiation. Brain radiation therapy can cause short-term memory problems, fatigue, nausea, and other side effects.

Therapy with radiation does not carry the risks of major surgery, but it can have too many and severe side effects. A reduced white blood cell counts, and low blood platelet levels also can occur with radiation therapy. Therapies with radiation can irritate the skin in the area that is treated.

Chemotherapy

Both NSCLC and SCLC may be treated with chemotherapy. According to allopathic theory, chemotherapy stop the growth of cancer cells by killing them or preventing them from dividing.

Chemotherapy may be given alone, as an adjuvant to surgical therapy, or in combination with radiotherapy. While several chemotherapeutic drugs have been developed, the class of drugs known as platinum-based drugs has been the most effective in the treatment of lung cancers.

For allopathic doctors, chemotherapy is the treatment of choice for most SCLC since these tumors are generally widespread in the body when they are diagnosed. Only half of the patients who have SCLC survive for four months without chemotherapy.

With chemotherapy, their survival time is increased up to eight to ten years. Chemotherapy alone is not particularly effective in treating NSCLC, but when NSCLC has metastasized, it can prolong survival in many cases.

Chemotherapy may be given as pills, as an intravenous infusion, or as a combination of the two. A combination of drugs is given in a series of treatments, called cycles, over weeks to months, with breaks in between cycles.

Side effects of Chemotherapy

The drugs used in chemotherapy also kill normally dividing cells in the body, resulting in unpleasant side effects. Damage to blood cells can result in increased susceptibility to infections and difficulties with blood clotting (bleeding or bruising easily). Other side effects include fatigue, weight loss, hair loss, nausea, vomiting, diarrhea, and mouth sores. The side effects of chemotherapy vary according to the dosage and combination of drugs used and may also vary from individual to individual.

Allopathic medications have been under experiments that can treat or prevent many of the side effects of chemotherapy.

Targeted therapy

Molecularly targeted therapy involves the administration of drugs that have been identified to work in subsets of patients whose tumors have specific genetic changes (driver mutations) that promote tumor growth.

EGFR-targeted therapies

The drugs “erlotinib, afatinib, and gefitinib” are examples of so-called targeted drugs that more specifically target cancer cells.

Erlotinib, gefitinib, and afatinib target protein “epidermal growth factor receptor” (EGFR) that is important in promoting the division of cells. The gene encoding this protein is mutated in many cases of non-small-cell lung cancer, creating a mutation that encourages tumor growth. Mutations in the EGFR gene are more common in cancers in women and in patients who have never smoked.

Drugs that target the EGFR receptor sometimes stop working after a time. Resistance often occurs because cancer has developed a new mutation in the same gene, and a common example of this is the so-called EGFR T790M mutation.

Some newer EGFR-targeted drugs also work against cells with the T790M mutation, including osimertinib. Necitumumab is another drug that targets EGFR. It can be used along with chemotherapy as the first treatment in people with advanced NSCLC of the squamous cell type.

Other targeted therapies

Other targeted drugs are available that target other driver mutations. Examples of these other targeted therapies include the ALK tyrosine kinase inhibitor drugs crizotinib, alectinib, brigatinib, lorlatinib, and ceritinib that are used in patients whose tumors have an abnormality of the ALK gene as the driver mutation. Some of these drugs may also be helpful for patients whose cancers have an abnormality of the gene known as ROS1.

The gene known as BRAF can also be abnormal in lung cancers causing the production of BRAF protein that promotes cancer growth. Dabrafenib is a type of drug known as a BRAF inhibitor and attacks the BRAF protein directly. Trametinib is known as a MEK inhibitor because it attacks MEK proteins, which are related to BRAF proteins. These may be used for patients with tumors that have abnormal BRAF genes.

Other attempts at targeted therapy include drugs known as anti-angiogenesis drugs, which block the development of new blood vessels within cancer. Without adequate blood vessels to supply oxygen-carrying blood, the cancer cells will die.

The antiangiogenic drug bevacizumab has also been found to prolong survival in advanced lung cancer when it is added to the standard chemotherapy regimen. Bevacizumab is given intravenously every two to three weeks. However, since this drug may cause bleeding, it is not appropriate for use in lung cancer patients who are coughing up blood, if the lung cancer has spread to the brain, or in people who are receiving anticoagulation therapy (“blood thinner” medications).

Bevacizumab also is not used in cases of squamous cell cancer because it leads to bleeding from this type of lung cancer. Ramucirumab is another angiogenesis inhibitor that can be used to treat advanced non-small-cell lung cancer.

Immunotherapy

Immunotherapy may be an effective option for some patients with advanced lung cancers. Drugs for immunotherapies work by strengthening the activity of the immune system against tumor cells. The immunotherapy drugs nivolumab and pembrolizumab are checkpoint inhibitors that target checkpoints or areas that control the immune response and promote the immune response.

These two drugs target the PD-1 protein, which strengthens the immune response against cancers. Atezolizumab and durvalumab are examples of drugs that target PD-L1, a protein related to PD-1 that is found on some tumor cells and immune cells.

Radiofrequency ablation (RFA)

Radiofrequency ablation is sometimes used for small tumors located near the outside of the lungs as an alternative to surgery, particularly in cases of early-stage lung cancer. In this type of treatment, a needle is inserted through the skin into the cancer, usually under guidance by CT scanning. Radiofrequency (electrical) energy is then transmitted to the tip of the needle where it produces heat in the tissues, killing the cancerous tissue and closing small blood vessels that supply cancer.

Unfortunately, all these therapies are on experimental bases and are still in the experimental stages, meaning that allopathic doctors do not yet have enough information to decide whether these therapies should become accepted forms of treatment for lung cancer or any type of cancer.

New allopathic drugs or new combinations of drugs are tested in clinical trials, which are studies that evaluate the effectiveness of new medications in comparison with those treatments already in widespread use. Newer types of immunotherapies are being studied that involve the use of vaccine-related therapies that attempt to utilize the body’s immune system to directly fight cancer cells.

Homeopathic treatment for Cancers

The aim of Homeopathy is not only to treat a type of cancer(s) and their symptoms but to address the underlying cause and individual susceptibility.

As far as therapeutic medication is concerned, several well-proved Homeopathic medicines are available for treatment of different types of cancers that can be selected on the basis of cause(s), condition, sensation, extension, location and modalities of the complaints.

That’s why for individualized remedy selection and treatment; the patient should consult a qualified Homeopathic doctor in person.

Exposure to any type of radiation is not an option, I (Dr Qaisar Ahmed) categorically reject radiations for any living thing. 

In any cancer’s treatment, the selection of medicine is based upon the theory of individualization and symptoms similarity by using holistic approach.

An astonishing claim of controversial folk healer Jim Kalmon treat cancers with a little baking soda and maple syrup.

Recipe

Mix one part baking soda with three parts maple syrup in a small saucepan.
Stir briskly. Heat for five minutes. Take one teaspoon daily.

Sodium bicarbonate is safe, extremely inexpensive and unstoppably effective when it comes to cancer tissues. It’s an irresistible chemical, cyanide to cancer cells, it hits the cancer cells with a shock wave of alkalinity, which allows much more oxygen into the cancer cells than they can tolerate. Cancer cells cannot survive in the presence of high levels of oxygen. Sodium bicarbonate is, for all intent and purposes, an instant killer of tumors. The extracellular (interstitial) pH (pHe) of solid tumors is significantly more acidic compared to normal tissues.

PH controls the speed of our body’s biochemical reactions. It does this by controlling the speed of enzyme activity as well as the speed that electricity moves through our body. The higher (more alkaline) the pH of a substance or solution, the more electrical resistance that substance or solution holds. Therefore, electricity travels slower with higher pH.

If we say something has an acid pH, we are saying it is hot and fast. Alkaline pH on the other hand, biochemically speaking, is slow and cool.

When oxygen enters an acid solution it can combine with H+ ions to form water. Oxygen helps to neutralize the acid, while at the same time the acid prevents oxygen from reaching the tissues that need it. Acidic tissues are devoid of free oxygen. An alkaline solution is just the reverse. Two hydroxyl ions (OH-) can combine to produce one water molecule and one oxygen atom. In other words, an alkaline solution can provide oxygen to the tissues.

At a pH slightly above 7.4 cancer cells become dormant and at pH 8.5 cancer cells will die while healthy cells will live.

Sodium Carbonate for poisoning

It is diazonium salt of carbonic acid and has been found effective in treating poisoning or overdose from many chemicals and allopathic/pharmaceutical drugs by negating the cardiotoxic and neurotoxic effects. Sodium bicarbonate is useful in treating neurological disorders in children.

Sodium and potassium bicarbonate helps to neutralize excess acids of any kind.

Part of any successful cancer treatment includes chelation and detoxification of heavy metals and a host of toxic chemicals (like mercury, uranium contamination is increasing, lead we are discovering is even more toxic than anyone ever believed and is even in the bread that we eat, arsenic is in broiler chicken, fluoride, chlorine is breathed in most showers etc).

The IMVA recommends alkaline foods and sodium bicarbonate so that the pH of the blood remains high, which in turn means that the blood is capable of carrying more oxygen. This in turn keeps every cell in the body at peak efficiency and helps the cell eliminate waste products. Detoxification and chelation will proceed more easily and safely under slightly alkaline conditions.

Increased urinary pH reduces oxidative injury in the kidney so it behooves us to work clinically with bicarbonate.

Vitamin D Deficiency Linked to Cancer

The main reason is that UVB rays from the sun produce vitamin D, and evidence links vitamin D deficiency with an increased risk of breast cancer.

In a 2008 case-control study published in the journal Carcinogenesis, researchers found that post-menopausal women with low vitamin D in the blood had an increased risk of breast cancer.

The study observed breast cancer patients between the ages of 50 and 74. In total, 1,394 cases and 1,365 controls were used in the study. Another case-control study from 2014 suggested that less than an hour of sunlight daily could reduce breast cancer risk.

How Sunlight Kills cancer?

As we know there is an anti-cancer link between vitamin D and breast cancer, but how?

The sunlight-induced vitamin D is thought to reduce the reproduction and spread of cancer cells and increase the occurrence of mutated cell self-eradication.

Vitamin D has to be converted into 1, 25-dihydroxycholecalciferol in the liver and kidney in the presence of PTH. The 1,25-dihydroxycholecalciferol is the active product.

There are various forms of vitamin D. But the most important one is vitamin D3 (also known as cholecalciferol).
Vitamin D3 is synthesized in the skin from 7-dehydrocholesterol, by the action of ultraviolet rays from the sunlight.

Activation of vitamin D3 occurs in two steps:

First step: –

Cholecalciferol (vitamin D3) is converted into 25- hydroxycholecalciferol in the liver. This process is limited. and is inhibited by 25-hydroxycholecalciferol itself by feedback mechanism.
This inhibition is essential for two reasons:
i. Regulation of the amount of active vitamin D.
ii. Storage of vitamin D for months together. If vitamin D3 is converted into 25-hydroxycholecalciferol, it remains in the body only for 2 to 5 days. But vitamin D3 is stored in liver for several months.

Second step: –

25-hydroxycholecalciferol is converted into 1,25- dihydroxycholecalciferol (calcitriol) in kidney. It is the active form of vitamin D3. This step needs the presence of PTH.

Role of Calcium Ion in Regulating 1, 25-Dihydroxycholecalciferol: –
When blood calcium level increases, it inhibits the formation of 1,25-dihydroxycholecalciferol.
The mechanism involved in the inhibition of the formation of 1,25-dihydroxycholecalciferol is as follows:

1. Increase in calcium ion concentration directly suppresses the conversion of 25-hydroxycholecalciferol into 1,25-dihydroxycholecalciferol. This effect is very mild.

2. Increase in calcium ion concentration decreases the PTH secretion, which in turn suppresses the conversion of 25-hydroxycholecalciferol into 1,25-dihydroxycholecalciferol. This regulates the calcium ion concentration of plasma itself indirectly, i.e. when the PTH synthesis is inhibited, the conversion of 25-hydroxycholecalciferol into 1,25-hydroxycholecalciferol is also inhibited. Lack of 1,25-dihydroxycholecalciferol decreases the absorption of calcium ions from the intestine, from the bones and from the renal tubules as well. This makes the calcium level in the plasma to fall back to normal.

Actions of 1, 25-Dihydroxycholecalciferol: –

1. It increases the absorption of calcium from the intestine, by increasing the formation of calcium binding proteins in the intestinal epithelial cells. These proteins act as carrier proteins for facilitated diffusion, by which the calcium ions are transported. The proteins remain in the cells for several weeks after 1,25-dihydroxycholecalciferol has been removed from the body, thus causing a prolonged effect on calcium absorption.
2. It increases the synthesis of calcium-induced ATPase in the intestinal epithelium
3. It increases the synthesis of alkaline phosphatase in the intestinal epithelium
4. It increases the absorption of phosphate from intestine along with calcium.

New Study about vit-D

A new study published in The Journal of Steroid Biochemistry and Molecular Biology last year found that vitamin D compounds suppress the breast cancer stem cell population, which may inhibit breast cancer growth.

Basically, radiation and chemotherapy do not shrink the tumor or kill the colony; the cancer stem cells remains but now more violent, which can cause an aggressive cancer recurrence in the near future. The chemotherapy and radiation pretty much just make the cancer stem cells angry.

The breast tissue abnormality ductal carcinoma in situ (DCIS) was once considered cancerous, but is now believed to be benign. DCIS may also progress to invasive ductal carcinoma (IDC), which is a more serious breast cancer risk, though it may not develop into breast cancer.

Conventional therapy “radiotherapy, chemotherapy, lumpectomies, and mastectomies for DCIS and IDC cases” do not work but aggravate the disease.

However, the aforementioned study found that the vitamin D3 compound BXL0124 normalized the Mammo sphere cell culture system (in Homeopathy there are lot of cases cured by Calcarea Carbonica), which included non-stem cell breast cells and breast cancer stem cells.

Vitamin D compounds also repressed cancer stem cell properties, the pluripotency markers OCT4 and KLF-4, and the cell markers CD44, CD49f, pNFkB, and c-Notch1. Simply put, vitamin D3 gives cancer stem cells a run for their money.

Other Ways to Reduce Breast Cancer Risk

Vitamin D3 may be a safe and effective alternative or complementary treatment to conventional breast cancer therapy. It is also considered a cost-effective preventative therapy against the recurrence of breast cancer.

Decreased dietary intake and/or absorption, certain malabsorption syndromes such as celiac disease, short bowel syndrome, gastric bypass, inflammatory bowel disease, chronic pancreatic insufficiency, and cystic fibrosis may lead to vitamin D deficiency. Lower vitamin D intake orally is more prevalent in the elderly population.

About 50% to 90% of vitamin D is absorbed through the skin via sunlight while the rest comes from the diet.

Twenty minutes of sunshine daily with over 40% of skin exposed is required to prevent vitamin D deficiency. Cutaneous synthesis of vitamin D declines with aging. Dark-skinned people have less cutaneous vitamin D synthesis. Decreased exposure to the sun as seen in individuals who are institutionalized or have prolonged hospitalizations can also lead to vitamin D deficiency. Effective sun exposure is decreased in individuals who use sunscreens consistently.

Individuals with chronic liver disease such as cirrhosis, hyperparathyroidism, renal failure and 1-alpha hydroxylase deficiency.

Homeopathic medicines for almost all types of cancers ♠

Plumbum Metallicum

Amaurosis. Anemia. Aneurysm. Anhidrosis. Atrophy. Bone exostoses. Brain softening; brain tumor. Bright’s disease. Cystitis. Dropsy. Dysuria. Emaciation. Epulis. Ganglion. Hemoptysis. Hyperesthesia. Hypopyon (accumulation of WBC in eyes). Ichthyosis. Intestinal obstruction. Intussusception. Jaw tumor. Bronchogenic carcinoma. Liver affections. Locomotor ataxy. Esophageal stricture. Paralysis – diphtheritic; agitans. Perichondritis. Proctalgia. Progressive muscular atrophy. Spinal sclerosis; spinal tumor. Spleen – affections. Stricture. Tabes mesenterica. Tobacco habit and related diseases. Tongue cancer – paralysis. Typhlitis. Umbilicus abscess. Vaginal spasm, virginal tumor, cancers. Vaginismus. Varicose.

Baryta Carbonica

Aneurysm. Apoplexy. Atrophy. Brain affections. Cysts. Foot-sweat. Glandular swellings. Heart affections. Esophageal spasm. Panaras. Parotitis. Prostate cancer. Tumors. Warts. Wens. Bronchogenic carcinoma.

Thuja Occidentalis

Abdomen distended, tumors. Anal fistula; fissure. Balanitis. Cancer. Catalepsy. Epulis. Eyes tumors; granular eye inflammation. Fatty tumors. Feet fetid. Flatus – incarcerated. Frontal sinuses catarrh. Ganglion. Gleet. Gonorrhea. Hemorrhage. Herpes zoster. Ichthyosis. Intussusception. Jaws – abnormal growth. Levitation. Morvan’s disease. Mucous patches. Muscae volitantes. Myopia. Naevus. Neck cracking. Onanism. Ovarian pain, tumors. Bronchogenic carcinoma. Paralysis. Pemphigus. Polypus. Prostate cancer. Ptosis. Ranula. Tongue ulcers, tumors; tongue biting. Tumors. Warts.

Hydrastis

Cancer. Chancroids. Chancroids. Constipation. Corns. Fistula. Jaundice. Leucorrhea. Lip cancer. Liver affections. Lumbago. Lupus. Menorrhagia. Metrorrhagia. Nails affections. Noises in the head. Ozaena. Placenta, adherent. Bronchogenic carcinoma. Deafness due to throat disease. Tongue affections. Ulcers. Uterus affections.

Calcarea Carbonica

Abdomen abnormally large. Anemia. Ankles weakness. Appetite depraved. Beard – sycosis. Bone diseases. Breasts painful. Bronchial glands affections. Calculus. Cancers. Caries. Debility. Delirium tremens. Diabetes. Dropsy. Fistula. Glandular swellings. Goiter. Herpes. Hydrocephalus. Hypochondriasis. Leucocythemia. Scrofula. Skin affections. Smell disorders. Bronchogenic carcinoma. Taste disordered. Tuberculosis. Tumors. Uterus, affections of. Varices. Vertigo. Warts.

Argentum Nitricum

Addison’s disease. Anemia. Chancre. Hands swelling. Impetigo. Locomotor ataxy. Neuralgia. Ophthalmia neonatorum. Paralysis. Prostate, enlargement of. Spinal irritation. Taste – altered. Throat affections. Tongue ulcerated. Warts. Bronchogenic carcinoma.

Cicuta Virosa

Cancer. Catalepsy. Bladder, paralysis of. Cerebro-spinal meningitis. Coccygodynia. Concussions. Convulsions. Facial eruption. Hysteria. Impetigo. Meningitis. Myelitis. Numbness. Esophageal stricture. Psoriasis. Puerperal convulsions. Bronchogenic carcinoma. Parasites, worms.

Belladonna

Abscess. Brain affections. Bronchial glands chronic diseases. Glandular swellings. Goiter. Gout. Kidney affections. Lung affections. Bronchogenic carcinoma. Malignant pustule. Meningitis. Nyctalopia. Paralysis. Para metritis. Perichondritis. Peri metritis. Peritonitis. Phlegmasia alba dolens. Pleurisy. Pneumogastric paralysis. Smell disordered. Taste, disordered. Tenesmus. Testicles affections. Throat chronic infections. Tongue affections. Tuberculosis. Ulcers. Uterine affections. Vaccinia.

Conium Maculatum

Asthma. Bladder inflammation. Breast affections; breasts painful. Bronchitis. Bronchogenic carcinoma. Cancer. Cataract. Chorea. Cough. Depression of spirits. Diphtheritic paralysis. Dysmenia (membranous). Erysipelas. Eyes affections. Galactorrhea. Herpes. Hypochondriasis. Jaundice. Liver – enlarged. Melancholia. Menstruation disorders. Numbness. Ovaries affections. Paralysis; Landry’s. Peritonitis. Phthisis. Painful breasts. Prostatitis. Ptosis. Scrofula. Sterility. Stomach, affections. Testicles affections. Tetters. Trismus. Tumors. Ulcers. Vertigo. Vision disordered. Wens.

Kalium Iodatum

Actinomycosis. Aneurysm. Anhidrosis. Bright’s disease. Bunions. Cancer. Bronchogenic carcinoma. Condylomas. Consumption/Tuberculosis. Cough. Croup. Debility. Dropsy. Otalgia; tinnitus. Emaciation. Erythema nodosum. Eyes affections; cysts on lids. Fibroma. Glandular swellings. Gonorrhea. Gout. Gumma. Hemorrhages. Hay fever. Housemaid’s knee. Influenza. Intra-menstrual hemorrhage. Joints affections. Laryngitis. Liver diseases. Locomotor ataxy. Lumbago. Lungs hepatization; Lung’s oedema. Menstruation disorders. Neuralgia. Nodes. Noises in ears. Nystagmus. Abnormal odor of body. Edema glottidis. Pancreatitis. Prostate diseases. Rheumatism. Rickets. Rupia. Spine, Pott’s curvature of. Spleen. Syphilis. Tic-douloureux. Tongue, neuralgia of. Tumors. Ulcers. Wens.

Arsenicum Bromatum

Glandular tumors and indurations, carcinoma, locomotor ataxia. Bronchogenic carcinoma.

Hydrastis Canadensis

Asthma. Cancer. Chancroids. Bronchogenic carcinoma. Gastric catarrh. Gonorrhea. Hemorrhoids. Jaundice. Leucorrhea. Lip cancer. Liver affections. Lumbago. Lupus. Menorrhagia. Metrorrhagia. Mouth, sore. Nails affections. Nipples, sore. Noises in the head. Stomach affections. Taste – disordered. Ulcers. Uterus affections.

Arsenicum Album

Abscess. Acne rosacea. Anemia. Aphthae. Asthma. Atrophy. Bronchitis. Brown-ague. Caecum affections. Cancer. Cancrum oris (oral cancer). Bronchogenic carcinoma. Dropsy. Duodenum. Dyspepsia. Hay-asthma. Herpes zoster. Hodgkin’s disease. Hydrothorax. Hypochondriasis. Ichthyosis. Indigestion. Jaundice. Lips eruption (around); Lips epithelioma. Locomotor ataxy. Lung affections. Lupus. Malignant pustule. Measles. Melancholia. Menstruation disorders. Miliary eruptions. Plethora. Pleurisy. Pleurodynia. Pneumonia. Tongue affections. Trachea affections. Ulcers. Vomiting. Whooping-cough. Yellow fever.

Chelidonium Majus

Antrum of Highmore, inflammation of. Cancer. Chest affections. Chorea. Constipation. Cough. Diarrhea. Dyspepsia. Gallstones. Gonorrhea. Hemoptysis. Hemorrhoids. Headache. Influenza. Jaundice. Lachrymal fistula. Laryngismus. Liver affections. Nephritis. Neuralgia. Nose-bleed. Pleurodynia. Pneumonia. Taste, altered. Tumors. Warts. Whooping-cough. Yawning.

Berberis Vulgaris

Biliary colic. Bilious attack. Bladder affections. Calculus. Duodenum – catarrh. Dysmenorrhea. Fevers. Fistula. Gallstones. Gravel. Herpes. Irritation. Jaundice. Joint affections. Knee, pain in. Leucorrhea. Liver disorder. Bronchogenic carcinoma. Ophthalmia. Oxaluria. Renal colic. Spleen affections. Tumors. Urine disorders. Vaginismus. Cancer.

Phosphorus

Alopecia areata. Bronchogenic carcinoma. Anemia, acute pernicious. Antrum disease. Asthma. Bone diseases. Brain affections; Brain softening. Brain-fag. Breast abscess; Breasts fistulas, cancers. Bronchitis – membranous. Cancer; bone cancer. Cataract. Intestinal catarrh. Chlorosis. Consumption. Corpulency. Cough. Dropsy. Ecchymosis. Fatty degeneration. Hemoglobinuria. Hemorrhagic diathesis. Hydrocephalus. Jaundice – malignancy; due to pregnancy; due to anemia. Levitation. Lienteries. Liver diseases; acute yellow liver atrophy.

Changed odor of body. Esophageal pain. Ozaena. Pancreatic disorders of. Paralysis – pseudo-hypertrophic; general insane/mania. Periostitis. Perspiration abnormal. Petit mal. Pneumonia. Polypus. Proctalgia. Proctitis. Progressive muscular atrophy. Immune thrombocytopenic purpura. Pylorus, thickening of. Retinitis. Rheumatism; paralytic. Shivering. Somnambulism. Spine curvature. Spleen enlargement. Sprains. Stammering or Stuttering. Throat mucus. Tobacco habit related diseases. Trachea tickling. Tuberculosis. Tumors – erectile, polypoid, cancerous. Vaccines side effects. Loss of voice. Whitlow. Yellow fever.

Fagonia Arabica (Cretica)

Inflammation and wound healing tissue scarring and accumulation of extracellular matrix properties, it repairs, and regeneration of injured tissue occur via apoptotic and regenerative mechanisms.  In liver cirrhosis, results of certain clinical trials are not so good, but it helps greatly in liver cirrhosis and liver cancer. In liver cancer stages Fegonia Arabica (Cretica) gives wonderful results.

It is the best blood purifier and decomposes blood clots, treat all types of Cancers, Bronchogenic carcinoma and Thalassemia, Treats all types of Hepatitis. Strengthens liver and prevents/cures liver cancer. vomiting, thirst and burning sensation in abdomen.

Mercurius Solubilis and Mercurius Vivid

Anemia. Bone disease. Brain inflammation. Breath offensive. Bronchitis. Bronchogenic carcinoma. Cancrum oris/Oral cancer. Catarrh. Chancre. Condylomas. Coughs. Fevers. Glandular swellings. Gout. Gumboil, unhealthy. Herpes. Jaundice. Joints affections. Liver affections. Lumbago. Measles. Melancholia. Meningitis. Mollities ossium. Mucous patches. Noises in the head. Odor of body offensive. Ovaries affections. Pancreatitis. Para metritis. Parotitis. Peritonitis. Prostate diseases. Purpura. Pyemia. Ranula. Rheumatism. Rigg’s disease. Salivation. Scurvy. Taste disorders. Teeth affections. Throat related deafness. Throat chronic soreness. Tongue affections: tongue mapped. Tremors. Typhus fever. Ulcers. Vaccination side effects. Vomiting.

Cholesternium

Cancer of the liver. Bronchogenic carcinoma. Obstinate hepatic engorgements. Burning pain inside; on walking holds his hand on side, hurts him so. Opacities of the vitreous. Jaundice; gallstones. Cholestenone is the physiological opponent of Lecithin. Both seem to play some unknown part in the growth of tumors. Gallstones and insomnia.

Hippozaeninum

Abscesses. Bed-sores. Boils. Bronchitis. Cancer. Carbuncles. Caries. Catarrh, chronic. Colds, chronic. Diphtheria. Elephantiasis. Erysipelas. Glanders. Glands, inflamed. Hip-disease. Liver, enlarged. Lupus exceeds. Nasal cartilages, ulceration of. Edema. Ozaena. Parotitis. Phlegmasia alba dolens. Phlegmon. Pustules. Putrid fever. Pyemia. Tuberculosis. Ulcers. Bronchogenic carcinoma.

Calceria Arsenicosa

Acidity. Albuminuria. Cirrhosis of liver. Bronchogenic carcinoma. Consumption. Corpulence. Embolus. Epilepsy. Gastric ulcer. Kidney’s affections. Liver affections. Palpitation. Pancreatic cancer. Tumors. Typhoid.

Conium Maculatum

Bladder inflammation. Breast affections; breasts painful. Bruises. Cancer. Diphtheritic paralysis. Bronchogenic carcinoma. Dysmenia (membranous). Erysipelas. Eyes affections. Galactorrhea. Herpes. Hypochondriasis. Jaundice. Liver enlarged. Melancholia. Menstruation, disordered. Numbness. Ovaries affections. Prostatitis. Testicles affections. Tetters. Trismus. Tumors. Ulcers. Vertigo. Wens.

Scirrhinum

Breast cancer. Cancer. Cancerous diathesis. Glands, enlarged. Hemorrhages. Varicose. Worms.

Cinnamomum Ceylanicum

Cancer where pain and fetor are present. Bronchogenic carcinoma. Its use in hemorrhages has abundant clinical verification. Nosebleed. Hemorrhages from bowels, hemoptysis, etc. A strain in loins or false step brings on a profuse flow of bright blood. Postpartum hemorrhage. Flatulence and diarrhea. Feeble patients with languid circulation.

Crotalus Horridus

Bilious fever. Cancers. Carbuncles. Cerebro-spinal meningitis. Chancre. Dark green vomiting immediately on lying on right side or back. Liver disorders. Black vomit. Jaundice; malignant jaundice with hemorrhage. Stools: black, thin, like coffee-grounds, offensive; dark green, followed by debility; yellow, watery with stinging in abdomen. Intestinal hemorrhage. Bronchogenic carcinoma.

Ornithogalum

Cancer. Flatulence. Gastric ulcer. Stomach, ulceration. Bronchogenic carcinoma.

Appis Melifestida

Abscess. Bladder affections. Carbuncle. Cancer. Vomiting of bile. Burning heat in the stomach. Constipation or Diarrhea – copious, blackish-brown, green, or whitish; orange-colored; greenish, yellow mucus; yellow watery; soft and pappy, mixed with serum; thin yellow; of infants. Diphtheria. Dissection wounds. Dropsy. Ear erysipelas. Erythema nodosum. Eyes affections; optic neuritis. Gangrene. Gout. Hands swelling. Bronchogenic carcinoma.

Hydrocephalus. Hydrothorax. Labia inflammation. Laryngitis. Lichen. Meningitis. Nasal redness. Ovaries pain; inflammation; tumors. Pancreatitis. Pannus. Peritonitis. Phlebitis. Prostatitis. Open non healing wounds. Throat chronic sore. Tongue edema; ulceration. Tracheal irritation. Tumors. Typhus. Urethritis. Urine abnormalities.

Kreosotum

Cancer. Bronchogenic carcinoma. Pains generally shooting, or tensive, or pressive, with swelling and induration of the hepatic region. Stinging pain in the liver. Sensation of fullness, and pain as from contusion, in liver. Pressure in region of spleen; the spot is painful to external pressure, diarrhea, or watery stools, papescent; dark brown; watery, putrid, containing undigested food; greyish or white; chipped, very fetid; frequent, greenish, watery; cadaverous smelling. Ineffectual painful urging. Hemorrhagic diathesis. Herpes. Hysterical vomiting. Lips epithelioma. Lupus. Menstruation disorders. Neuralgia. Ovary affections. Prostate irritation.

Conium Maculatum

Conium maculatum is an excellent medicine for breast cancer where mammary glands are hard and sore and is scirrhous adenocarcinomas, which begins in the ducts and invades the parenchyma. Sometimes the condition is associated with the inflammation of breast tissue. Breast hard and nodular, tender to touch. Bronchogenic carcinoma. Piercing pains. Burning and stinging pain in the breast. The skin over the tumor is adherent.

Discharge of pus from nipple. Breast is hard, almost cartilaginous. The edges are distinct serrated and irregular, associated with productive fibrosis. Breasts are painful even to the touch of the clothes or the jar of walking. Cancer after injury (like a blow) or trauma to breast.

Hydrastis canadensis

Indurated glands. Swelling of the mammary glands. Cancer. Chancroids. Bronchogenic carcinoma. Fistula. Gastric catarrh. Hemorrhoids. Jaundice. Lip cancer. Liver affections. Lupus. Menorrhagia. Metrorrhagia. Mouth sore. Nails affections. Nipples sore. Taste disorders. Throat related deafness. Throat chronic infections. Tongue affections. Typhus. Ulcers. Uterus affections.

Iodium

Appetite disordered. Brain atrophy. Breasts affections. Cancer. Chilblains. Chyluria. Constipation. Consumption. Coryza. Cough. Croup. Debility. Jaundice. Lactation disorders. Laryngitis. Liver affections. Lymphatic swellings. Melancholia. Ovaries affections; ovarian dropsy. Ozaena. Prostate gland, enlarged. Rheumatic gout. Rheumatism. Salivation. Scars. Throat affections. Uterus affections. Voice affections. Vomiting.

Phytolacca

Bone diseases; Bone tumors. Breasts affections. Cancer. Cholera. Cicatrix. Cough. Eustachian tubes affections. Glands enlarged. Gleet. Glossitis. Granular conjunctivitis. Hemorrhoids. Hearing altered. Lichen. Liver affections. Lumbago. Lupus. Mouth ulcers. Nipples – sore and painful. Nursing painful. Orchitis. Parotitis. Prostate affections. Rectal cancer. Respiration abnormal. Sewer-gas poisoning. Bronchogenic carcinoma.

Calcarea Fluor

Calcarea fluor corresponds to hard indurated swellings. Fibroadenomas as well as breast cancer. Bronchogenic carcinoma. Adenoids. Aneurysm. Bone affections. Breast indurations. Cold sores. Corneal opacities. Cough. Exostosis. Glands indurated. Hemoptysis. Herpes. Liver affections.

Some other Homeopathic medicines commonly used for cancer:

Arsenicum Iodatum, Acalypha Indica, Alumina, Ammonium Carbonicum, Andrographis or Andrographolide, Anthemis Nobilis, Apis Mellifica, Aranea Diadema, Argentum Metallicum, Argentum Nitricum, Artemisia Vulgaris, Astragalus, Aurum Arsenicum, Aurum Iodatum, Aurum Metallicum, Aurum Muriaticum, Natronatum.

Bromium, Caladium Seguinum, Cadmium Metallicum, Carcinosinum (in high), Carbo Vegetabilis, Calcarea Fluorata, Causticum, Cistus Canadensis, Cobaltum Metallicum, Cobaltum Nitricum, Collinsonia Canadensis, Condurango, Conium Maculatum, Crotalus Horridus, Elaps Corallinus, Euphorbium. Folliculinum. Graphites, Hippozaeninum (in high.), Hydrastis. Iodum, Ionised Radiation. Kali Carbonicum, Kali Iodatum. Lachesis Mutus, Lapis Albus, Lilium Tigrinum, Methylenum Coeruleum. Nitricum Acidum. Phosphorus, Platinum Metallicum, Phytolacca. Scirrh.(100), Sepia Succu, Silicea (100), Silica Terra, Staphysagria Sulphur, Sulphuric Acid, Symphytum Officinale. Terebinthinate Oleum, Tetramethylpyrazine, Teucrium Marum Verum, Theridion Curassavicum, Tuberculinum Bovinum. Viscum Album.

In case if urinary tract is involved try to select from following medicines:

Anilinium. Arsenicum Album. Asparagus Officinalis. Barosma. Crenulatum. Atropa Belladonna. Benzoicum Acidum. Berberis Vulgaris. Cannabis Sativa. Cantharis Vesicatoria. Meloe Vesicatorius. Chimaphila Umbellata. Erythroxylum Coca. Crotalus Horridus. Curare Woorari. Epigaea Repens. Formica Rufa. Helonias Dioica. Hepar Sulphuris Calcareum. Kali Iodatum, Kali Hydriodicum. Kali Phosphoricum. Mercurius Solubilis Hahnemanni. Moschus Moschiferous. Nitricum. Acidum. Phosphorus. Populus Tremuloides. Sarsaparilla Officinalis. Solidago Virga. Aurea. Veratrum Viride.

P. S: This article is only for doctors having good knowledge about Homeopathy and allopathy, for learning purpose(s).

For proper consultation and treatment, please visit our clinic.

None of above-mentioned medicine(s) is/are the full/complete treatment but just hints for treatment; every patient has his/her own constitutional medicine.

Dr. Sayyad Qaisar Ahmed (MD {Ukraine}, DHMS), Abdominal Surgeries, Oncological surgeries, Gastroenterologist, Specialist Homeopathic Medicines.

  Senior research officer at Dnepropetrovsk state medical academy Ukraine.

Location:  Al-Haytham clinic, Umer Farooq Chowk Risalpur Sadder (0923631023, 03119884588), K.P.K, Pakistan.

Find more about Dr Sayed Qaisar Ahmed at:

https://www.youtube.com/Dr Qaisar Ahmed

https://www.facebook.com/ahmed drqaisar

https://www.drqaisarahmed.com